The CLOSER trial: a multi-center study on the clinical safety and effectiveness of CloserTM VSS, a novel resorbable transfemoral vascular access sealing system.
Shing Chiu WongRoger GammonWilliam BachinskyCharles O'ShaughnessyWayne LeimbachNelson BernardoNick CavrosMichael R JaffPing-Yu LiuGeoffrey BergmanPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
In patients undergoing 5-7 Fr transfemoral diagnostic and interventional procedures, the CLOSER Trial met both its primary effectiveness and safety PGs. Immediate hemostasis was achieved in the majority of patients without major complication.
Keyphrases
- patients undergoing
- transcatheter aortic valve replacement
- end stage renal disease
- transcatheter aortic valve implantation
- study protocol
- clinical trial
- randomized controlled trial
- newly diagnosed
- ejection fraction
- aortic valve replacement
- phase ii
- systematic review
- prognostic factors
- peritoneal dialysis
- coronary artery disease
- left ventricular